Table 1 |
|
|
Reasons to Suspect AL Amyloidosis |
|
|
1. |
Non-diabetic nephrotic syndrome |
|
2. |
Non-ischemic cardiomyopathy and hypertrophy* |
|
3. |
Hepatomegaly or increased alkaline phosphatase** |
|
4. |
Monoclonal gammopathy with |
|
a. Autonomic or sensory neuropathy |
|
|
b. Unexplained fatigue |
|
|
c. Edema |
|
|
d. Unintentional weight loss |
|
|
|
|
|
Signs and symptoms that may represent AL amyloidosis in a patient. Non-diabetic nephrotic syndrome; non-ischemic cardiomyopathy and hypertrophy on echocardiogram, especially in the absence of hypertension*; hepatomegaly or increased alkaline phosphatase with no liver abnormalities by imaging**; or autonomic neuropathy with orthostasis or sensory neuropathy with a monoclonal protein. In patients with monoclonal gammopathy and unexplained fatigue, edema, weight loss or paresthesias, AL amyloidosis should also be considered. |
|
|
Rosenzweig and Landau Journal of Hematology & Oncology 2011 4:47 doi:10.1186/1756-8722-4-47 |
|